Related references
Note: Only part of the references are listed.Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease
Rebecca Saich et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
A phase I study of visilizumab a humanized anti-CD3, monoclonal antibody, in severe steroid-refractory ulcerative colitis
Scott Plevy et al.
GASTROENTEROLOGY (2007)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease
DH Adams et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Medical progress: Autoimmune hepatitis
EL Krawitt
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors
J Croese et al.
GUT (2006)
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
B Keymeulen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis
B Eksteen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
OKT3 (muromonab-CD3) associated hepatitis in a kidney transplant recipient
MR Go et al.
TRANSPLANTATION (2002)
Biologic therapy of inflammatory bowel disease
WJ Sandborn et al.
GASTROENTEROLOGY (2002)
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease
PA Carpenter et al.
BLOOD (2002)
HuM291 (NUVION), a humanized Fc receptor-nonbinding antibody against CD3, anergizes peripheral blood T cells as partial agonist of the T cell receptor
LA Chau et al.
TRANSPLANTATION (2001)
Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors
DJ Norman et al.
TRANSPLANTATION (2000)
Advances in immunology: The immune system - Second of two parts.
PJ Delves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The immune system - First of two parts
PJ Delves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
In vitro characterization of five humanized OKT3 effector function variant antibodies
DL Xu et al.
CELLULAR IMMUNOLOGY (2000)
Share Paper
